The Danish drugmaker Novo Nordisk argues that semaglutide, the active ingredient in Ozempic and Wegovy, are too complex for those manufacturers to make safely.
Related Posts
Norway hits pause on controversial deep-sea mining plans
Norway has shelved plans to open a vast ocean area at the bottom of the Arctic for commercial-scale deep-sea mining.
Watch SpaceX launch Starship’s fourth flight of the year
SpaceX is set to attempt its sixth Starship test flight to date on Tuesday.
‘Europe’s Detroit’ built a thriving car industry. Trump tariffs now threaten to unravel its success
A small landlocked country in the heart of Europe appears to be uniquely exposed to President-elect Donald Trump’s “America First” economic agenda.